The weekly litigation news digest is live. Subscribe now

IP Verse

Immunotherapy Using Redirected Allogeneic Cells - EP2566954

The patent EP2566954 was granted to Yeda Research on Nov 2, 2022. The application was originally filed on May 4, 2011 under application number EP11778231A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2566954

YEDA RESEARCH
Application Number
EP11778231A
Filing Date
May 4, 2011
Status
Patent Maintained As Amended
Sep 30, 2022
Publication Date
Nov 2, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GRUNDMay 27, 2019GRUND -

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTWO0031239
OPPOSITIONEP2566954
OPPOSITIONUS2008267972
OPPOSITIONUS6544787
OPPOSITIONUS7943180
OPPOSITIONWO2011140170

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents